Latham & Watkins Advised On Brightspring’s Secondary Offering Of Common Stock And Concurrent Share Repurchase

Latham & Watkins Advised on BrightSpring’s Secondary Offering of Common Stock and Concurrent Share Repurchase

Latham & Watkins advised BrightSpring Health Services, Inc. (NASDAQ: BTSG) (BrightSpring), a leading home and community-based health services platform, focused on delivering complementary pharmacy and provider services to complex populations, has announced the pricing of an underwritten secondary offering by certain of its stockholders (the selling stockholders), including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain members of management, of an aggregate 20,000,000 shares of common stock of BrightSpring, at the public offering price of US$41.15 per share. No shares are being sold by BrightSpring in the offering. The selling stockholders will receive all of the proceeds from this offering. The offering is expected to close on March 4, 2026, subject to customary closing conditions.

The Latham & Watkins LLP team led by Marc Jaffe (Partner), Ian Schuman (Partner), and Kaj Nielsen (Partner), with Molly Mitchell (Associate). Advice was also provided on healthcare matters by Nicole Liffrig Molife (Counsel), with Margaret Rote (Associate), and on tax matters by Elena Romanova (Partner), with Jack Santoro (Associate).

Click to know more about  Latham & Watkins

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.